Legend Biotech (LEGN) Current Leases (2019 - 2026)
Legend Biotech's (LEGN) quarterly Current Leases came in at $11.2 million in Q1 2026, up 109.7% YoY from $5.3 million in Q1 2025, and up 51.35% on a QoQ basis from $7.4 million in Q4 2025.
Legend Biotech (LEGN) Current Leases (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Current Leases data on file, last reported at $11.2 million in Q1 2026.
- Quarterly Current Leases rose 109.7% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (up 109.7% YoY) and the FY2025 annual result came in at $7.4 million, up 54.17% from the prior year.
- Current Leases advanced to $11.2 million in Q1 2026, from $7.4 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $11.2 million in Q1 2026 to a low of $2.9 million in Q3 2023.
- A 5-year average of $5.0 million and a median of $4.3 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases jumped 218070.95% — and 2024, when it sank 32.19%.
- Tracing LEGN's Current Leases over 5 years: stood at $3.6 million in 2022, then retreated by 10.89% to $3.2 million in 2023, then surged by 51.18% to $4.8 million in 2024, then surged by 54.17% to $7.4 million in 2025, then surged by 51.35% to $11.2 million in 2026.
- The last three Current Leases figures came in at $11.2 million (Q1 2026), $7.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 11.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.80 Mn |
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 5.91 Mn |
| Mar 31, 2025 | 5.34 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 3.56 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Dec 31, 2021 | 911,000.00 |
| Sep 30, 2021 | 1.87 Mn |
| Jun 30, 2021 | 1,621.00 |
| Mar 31, 2021 | 1,673.00 |